The estimated Net Worth of John P Groetelaars is at least $15.3 Milhão dollars as of 12 November 2021. Mr. Groetelaars owns over 5,193 units of Hill-Rom Inc stock worth over $6,248,225 and over the last 8 years he sold HRC stock worth over $1,737,800. In addition, he makes $7,326,160 as President, Chief Executive Officer, e Director at Hill-Rom Inc.
John has made over 12 trades of the Hill-Rom Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 5,193 units of HRC stock worth $809,900 on 12 November 2021.
The largest trade he's ever made was exercising 23,687 units of Hill-Rom Inc stock on 10 August 2017 worth over $2,762,615. On average, John trades about 4,046 units every 65 days since 2016. As of 12 November 2021 he still owns at least 40,063 units of Hill-Rom Inc stock.
You can see the complete history of Mr. Groetelaars stock trades at the bottom of the page.
John P. Groetelaars is President, Chief Executive Officer, Director of the company. John Groetelaars most recently served as executive vice president and president of the Interventional Segment at Becton, Dickinson and Company, which he joined in December 2017 following its acquisition of C.R. Bard Inc. He previously served in a variety of progressive roles at C.R. Bard during his 10-year career there, including as a group president from 2015 to 2017. Mr. Groetelaars joined C.R. Bard in 2008 as vice president and general manager, Davol Inc., and was appointed president of Davol in 2009. In 2013, Mr. Groetelaars was promoted to group vice president and in 2015 he was promoted to group president, a position he held until C.R. Bard was acquired by Becton, Dickinson and Company in December 2017. Prior to joining C.R. Bard, Mr. Groetelaars held various international leadership positions in Canada, Denmark and the United Kingdom at Boston Scientific Corporation from 2001 until 2008. Prior to joining Boston Scientific, Mr. Groetelaars held positions in general management, marketing, business development and sales with Guidant Corporation and with Eli Lilly.
As the President, Chief Executive Officer, e Director of Hill-Rom Inc, the total compensation of John Groetelaars at Hill-Rom Inc is $7,326,160. There are no executives at Hill-Rom Inc getting paid more.
John Groetelaars is 54, he's been the President, Chief Executive Officer, e Director of Hill-Rom Inc since 2018. There are 12 older and 12 younger executives at Hill-Rom Inc. The oldest executive at Hill-Rom Holdings Inc is William Kucheman, 70, who is the Independent Director.
John's mailing address filed with the SEC is C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC, 28277.
Over the last 17 years, insiders at Hill-Rom Inc have traded over $30,589,508 worth of Hill-Rom Inc stock and bought 112,784 units worth $2,597,878 . The most active insiders traders include John J Greisch, W August Hillenbrand, eJames R Giertz. On average, Hill-Rom Inc executives and independent directors trade stock every 20 days with the average trade being worth of $1,650,525. The most recent stock trade was executed by Andreas G Frank on 6 December 2021, trading 361 units of HRC stock currently worth $56,302.
Hillrom Holdings Inc. is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, its innovations touch over 7 million patients each day. They help enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. The company makes these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory health devices, advanced operating room equipment and more, delivering actionable, real-time insights at the point of care.
Hill-Rom Inc executives and other stock owners filed with the SEC include: